Skip to main content
Preventive Medicine Reports logoLink to Preventive Medicine Reports
. 2024 Jan 12;38:102607. doi: 10.1016/j.pmedr.2024.102607

Pairwise association of key lifestyle factors and risk of solid cancers - A prospective pooled multi-cohort register study

Eira Roos a,1,⁎, Sanna Heikkinen b,1, Karri Seppä b, Olli Pietiläinen a, Heidi Ryynänen b, Maarit Laaksonen c,d, Teemu Roos e, Paul Knekt c, Satu Männistö c, Tommi Härkänen c, Pekka Jousilahti c, Seppo Koskinen c, Johan G Eriksson c,g,h, Nea Malila b, Ossi Rahkonen a, Janne Pitkäniemi b,f,a
PMCID: PMC10828451  PMID: 38298822

Abstract

Smoking, alcohol consumption, obesity, and physical inactivity are key lifestyle risk factors for cancer. Previously these have been mostly examined singly or combined as an index, assuming independent and equivalent effects to cancer risk. The aim of our study was to systematically examine the joint pairwise and interactive effects of these lifestyle factors on the risk of a first solid primary cancer in a multi-cohort prospective setting.

We used pooled data from seven Finnish health survey studies during 1972–2015, with 197,551 participants diagnosed with 16,373 solid malignant primary tumors during follow-up. Incidence of any cancer was analyzed separately without and with lung cancers using Poisson regression with main and interaction effects of key lifestyle factors.

When excluding lung cancer, the highest risk of any cancer in men was observed for smokers with a BMI of ≥25 kg/m2 (HR 1.36, 95 % CI 1.25–1.48) and in women for smokers consuming alcohol (HR 1.22, 1.14–1.30). No statistically significant interactions between any studied risk factor pairs were observed. When including lung cancer, the highest HRs among men were observed for smokers who consume alcohol (HR 1.72, 1.57–1.89) and among women for smokers who were physically inactive (HR 1.38, 1.27–1.49).

Smoking combined with other lifestyle factors at any exposure level resulted in highest pairwise risks, both in men and women. These results highlight the importance of smoking prevention, but also the importance of preventing obesity and reducing alcohol consumption.

Keywords: Cancer, Smoking, Alcohol consumption, Obesity, Physical activity, Lifestyle habits

1. Introduction

Cancers are the leading cause of premature death in most Western countries (Wild et al., 2020). Both cancer incidence and prevalence are on the rise as life expectancy increases and evolving cancer treatments augment cancer survival (Torre et al., 2016). It is estimated that by the year 2040 global cancer burden exceeds 27 million new cancer cases annually, compared with the 18 million new cases worldwide in 2018 (Wild et al., 2020). In addition to human suffering, the economic burden associated with cancer is also rising. The total annual economic cost of cancer worldwide was already around US$1.16 trillion during 2010 (Wild et al., 2020). In future, keeping cancer in remission may require long periods of high-cost treatment and even more health care resources (Howard et al., 2015, Meropol et al., 2009).

According to the International Agency for Research on Cancer (IARC), 30–50 % of all the cancers could be prevented by influencing modifiable lifestyle factors (Wild et al., 2020). For population cancer burden, tobacco smoking is the most important factor with estimates of population attributable fractions around 20 % in men and 10–15 % (Olsen et al., 1997, Poirier et al., 2019) in women. However, there is evidence of the increasing role of other lifestyle factors for the cancer burden: While smoking is associated with approximately 20 different cancers, including respiratory and gastrointestinal (gi) tract cancers (Wild et al., 2020), alcohol consumption, for instance, is associated with increased risk of gi and urinary tract cancers and breast cancer (Wild et al., 2020). Physical activity is associated with reduced gi-tract and gynecological cancer risks (Wild et al., 2020), while obesity increases the risk of at least 13 different cancers, including gi-tract cancers, postmenopausal breast cancer and kidney cancer (Wild et al., 2020).

In earlier research, the effects of lifestyle factors have been commonly reported for a single factor at a time adjusted for other lifestyle factors with an assumption of their independent effects (Dartois et al., 2014, Parkin et al., 2011 Dec, Katzke et al., 2015). Examining joint effects of multiple lifestyle factors would be important from the point of view of cancer prevention programs, but this is challenging due to the required sample sizes needed to achieve sufficient statistical power. This has been circumvented in some studies by focusing on a selected subset of lifestyle factor combinations (Hadrien et al., 2013) or by constructing lifestyle indices wherein the lifestyle factors are encoded as a sum of the component factors (Naudin et al., 2020).

Some interactive effects have been found between certain hazardous exposures and risk of some cancers (Levi, 1999). Considering lifestyle factors, there is some evidence on interaction between smoking and alcohol consumption in relation to specific cancers (Steevens et al., 2010, Maasland et al., 2014, Ramroth et al., 2004, Viner et al., 2019). Alcohol may act as a solvent for tobacco carcinogens thus making tobacco more toxic (IARC, 2012), and as smoking affects central fat distribution (Chiolero et al., 2008), it may influence hormonal activity of the fat tissue thus affecting the cancer risk related with obesity. Regarding body weight and physical exercise, it has been shown that physical activity appears to decrease the risk of pancreatic cancer, especially among those who are overweight (Michaud et al., 2001).

The aim of this study was to systematically examine the joint pairwise and interactive effects of smoking, alcohol consumption, body weight and physical inactivity with the risk of a first solid primary cancer in a multi-cohort prospective setting both excluding and including lung cancers due to the strong known association with smoking.

2. Material and methods

We used data pooled for the METCA consortium (Prospective Meta-Cohort Study of Cancer Burden in Finland, (Pitkäniemi et al., 2020)). The study covers the following survey studies monitoring health behavior in Finland in 1972–2015: The National FINRISK Study conducted at 5-year intervals since 1972 (FINRISK, (Borodulin et al., 2018)), The Adult Health, Wellbeing, and Services Studies from 2010 to 2011 (ATH1) and from 2012 to 2015 (ATH2, (Härkänen et al., 2014)), The Health 2000 Survey (H2000, (Heistaro, 2008)), The Follow-up of the Finnish Mobile Clinic Health Examination from 1972 to 1977 (FMCF, (Knekt et al., 2017)) and the Mini-Finland Health Survey from 1978 to 1980 (MFH, (Knekt et al., 2017)), the Helsinki Health Study from 2000 to 2002 (HHS, (Lahelma et al., 2013)) and The Helsinki Birth Cohort Study (HBCS, (Eriksson, 2006)). Exposure assessment includes both survey data and health examinations.

The cohort participants were individually followed-up with personal identity codes through register linkage to the nation-wide population-based Finnish Cancer Registry for cancers and the Population Register Centre for deaths. Cancer data cover the entire target population and have been validated with high coverage of solid cancers (96 %), i.e., it is unlikely that incident cancers are missed (Leinonen et al., 2017). The follow-up started from the date of baseline survey or the date when the person turned 30 years, which ever occurred latest, and continued until the end of 2013 or 2015 (depending on the cohort), death or emigration, which ever earliest (Pitkäniemi et al., 2020).

Total of 16,373 solid malignant primary tumors (excluding skin non-melanoma but including benign central nervous system tumors) among 197,551 persons were diagnosed during the follow-up of 2,305,658 person years (Table 1). The largest numbers of cases were observed for cancers of the prostate (N = 2904), breast (N = 2825), lung (N = 1914), colorectum (N = 1650) and bladder and urinary tract (N = 702). All the analyses of pairwise effects were done separately without and with lung cancers. The largest individual study cohorts were ATH1 and ATH2 (n = 70,043, see Appendix I) and FINRISK (n = 51,415), but longest follow-up times and substantial number of person-years were obtained from the FMCF (369,451 person-years), MFH (133,825) and FINRISK (795,228).

Table 1.

Descriptive statistics of the METCA consortium, adult cohort, 1972–2015, Finland.

Population characteristics Total Men Women
Years of baseline of harmonized cohort 1972–2015
N of subjects in harmonized cohort 197,551 88,963 108,588
Person years (in thousands) 2306 1046 1260
Solid malignant tumors 16,373 8469 7904
Lung cancers 1914 1514 400
Age distribution of tumors (incl. lung)
30–49 959 266 693
50–69 7950 4029 3921
70+ 7464 4174 3290
Follow-up years (median (SD)) 6 (12) 6 (12) 6 (13)
Age at baseline (mean (SD)) 53 (16) 52 (16) 53 (17)
Proportion of men/women (%) 45/55

Smoking, alcohol consumption, body mass index (BMI), and physical inactivity measures were harmonized between the study cohorts and categorized into those exposed and those not exposed. Smoking was grouped into never-smokers (reference, not exposed) and smokers (ex- and current smokers). Regarding alcohol use, subjects reporting using 0 g of alcohol per week (MFH, HHS), per month (FMCF), never use of alcohol (FINRISK, H2000, HBCS), or not using alcohol within the past year (ATH) were categorized as non-exposed. Accordingly, subjects reporting any, ever, or current use of alcohol were considered as exposed. Applicable information on alcohol use was not available in the FINRISK 1982 survey. Body mass index was divided into those with BMI < 25 kg/m2 (reference; not exposed) and having overweight (BMI ≥ 25 kg/m2, exposed). Physically inactive (no leisure time physical activity) were categorized into exposed and physically active into not exposed (reference, those with any leisure time activity). Missing item values of a covariate were handled as a separate category in the analysis.

For each pair of lifestyle factors we calculated the sum of person years, the number of first primary solid malignant tumors, and the incidence rate standardized to the age structure of the World 1966 population. The hazard ratios (HRs) of lifestyle factors for solid malignant tumor were estimated using Poisson regression models based on multiplicative hazard functions as described in the following paragraph. As sensitivity analyses, we estimated the HRs by excluding the first two years of follow-up.

Let Capsx be the number of cancer cases among persons in age group a, calendar period p (five-year periods) and survey study s with vector x=x1,x2,x3,x(4) of values of four lifestyle factors. The number of cases is described by the Poisson distribution CapsxPoissonλapsxyapsx where λapsx is the cancer incidence rate and yapsx is the number of persons years in the stratum. In the first model, we included only the main effects of the lifestyle factors:

logλapsx=αaps+βx11+βx22+βx33+βx44 (1)

where expαaps is the baseline hazard, βxii=0 is the reference level of factor i, and expβxii is the multiplicative main effect of factor i with value xi. The baseline hazard was stratified by age (5-year groups of attained age) and calendar time (5-year periods) to account for variation in the hazard by age and period, and variation in the baseline hazard between studies was modelled by multiplicative study-specific effects: αaps=αap+δs. In model M1, we assumed the main effects model for the lifestyle factors, i.e., the HR of two factors was the product of the HRs of each lifestyle factor, and made the common statistical assumption of proportional hazards, i.e., the HRs were constant in time. In an alternative model, M2 for each pair i,j of lifestyle factors separately, the interaction term γxi,xjij of the factors with values xi,xj was added to model M1:

logλapsx=αaps+βx11+βx22+βx33+βx44+γxi,xjij (2)

where βxii=0 is the reference level of factor i, and if xi or xj is the reference level or missing, then γxi,xjij=0. HRs of main effects expβxii and expβxjj, pairwise effect expβxii+βxjj+γxi,xjij and multiplicative interaction expγxi,xjij are reported with their 95 % confidence intervals (CI). To test interaction for pairs of lifestyle factors, we compared the fit of models M1 and M2 by using the likelihood ratio test. Models M1 and M2 were fitted separately for men and women. P-values were adjusted for multiple testing using the method of Benjamini and Hochberg (Benjamini and Hochberg, 1995). Statistical analyses were conducted in statistical program R version 4.0.5 using popEpi package version 0.4.10.

The study was approved by The Finnish Institute for Health and Welfare (Permits no. THL/1091/6.02.00/2015 and THL/679/6.02.00/2018), which include evaluation of informed consent of each participating study cohort. Cancer data was obtained according to national legislation of secondary use of health and social data (Act on the Secondary Use of Health and Social Data, 552/2019 and Act on the National Institute for Health and Welfare, 668/2008).

3. Results

The prevalence of the risk factors in all study subjects and in subjects diagnosed with cancer are presented in Table 2A. About half of the survey respondents were never smokers and half former or current smokers (47 % and 51 %, respectively). One fifth reported no use of alcohol (22 %), 41 % had a BMI < 25 kg/m2 and 71 % reported being active during leisure time. Prevalence of all pairwise-categorized lifestyle factors for men and women and separately for subjects diagnosed with cancer are shown in Table 2B. The proportion of subjects with non-exposed lifestyle factor pairs varied from 9 % (N = 17,022) for non-alcohol users with BMI < 25 kg/m2 to 35 % (N = 66,727) for physically active never smokers.

Table 2A.

Prevalence of risk factors in all study subjects and in subjects diagnosed with cancer. METCA consortium, adult cohort, 1972–2015, Finland.

Risk factors All study subjects
Subjects diagnosed with cancer
Total
Men
Women
Total
Men
Women
N % N % N % N % N % N %
Smoking Never smoker 93,433 47 28,013 31 65,420 60 7722 47 1803 25 5919 64
Ex or current smoker 99,882 51 59,181 67 40,701 37 8354 51 5192 73 3162 34
Missing 4236 2 1769 2 2467 2 297 2 110 2 187 2
Alcohol No use of alcohol 43,692 22 12,541 14 31,151 29 3798 23 921 13 2877 31
Use alcohol 148,293 75 74,353 84 73,940 68 12,250 75 6070 85 6180 67
Missing 5566 3 2069 2 3497 3 325 2 114 2 211 2
Body mass index Normal weight 81,186 41 32,294 36 48,892 45 7400 45 2910 41 4490 48
Overweight or obese 108,926 55 53,518 60 55,408 51 8672 53 4056 57 4616 50
Missing 7439 4 3151 4 4288 4 301 2 139 2 162 2
Physical inactivity Any leisure time exercise 139,799 71 64,240 72 75,559 70 11,280 69 5016 71 6264 68
No leisure time exercise 52,459 27 22,336 25 30,123 28 4706 29 1889 27 2817 30
Missing 5293 3 2387 3 2906 3 387 2 200 3 187 2

Table 2B.

Prevalence of risk factor pairs in all study subjects and in subjects diagnosed with cancer. METCA consortium, adult cohort, 1972–2015, Finland.

All study subjects
Subjects diagnosed with cancer
Total

Men

Women

Total

Men

Women

Risk factor pair N % N % N % N % N % N %
Smoking Alcohol
Never-smoker No use of alcohol 31,564 17 5991 7 25,573 25 2903 18 416 6 2487 28
Use alcohol 59,752 31 21,560 25 38,192 37 4678 30 1359 20 3319 37
Ex- or current smoker No use of alcohol 11,472 6 6315 7 5157 5 852 5 490 7 362 4
Use alcohol 87,133 46 52,158 61 34,975 34 7418 47 4657 67 2761 31



Smoking Body mass index
Never-smoker Normal 39,441 21 10,855 13 28,586 28 3441 22 755 11 2686 30
Overweight or obese 50,657 27 16,246 19 34,411 34 4155 26 1019 15 3136 35
Ex- or current smoker Normal 40,414 22 20,937 25 19,477 19 3851 24 2120 31 1731 19
Overweight or obese 56,391 30 36,454 43 19,937 19 4385 28 2992 43 1393 16



Smoking Physical inactivity
Never-smoker Any leisure time exercise 66,727 35 21,566 25 45,161 43 5185 33 1364 20 3821 43
No leisure time exercise 24,622 13 5876 7 18,746 18 2372 15 394 6 1978 22
Ex- or current smoker Any leisure time exercise 71,152 38 41,877 49 29,275 28 5907 37 3593 53 2314 26
No leisure time exercise 27,014 14 16,171 19 10,843 10 2292 15 1481 22 811 9



Alcohol Body mass index
No use of alcohol Normal 17,022 9 5157 6 11,865 12 1440 9 400 6 1040 12
Overweight or obese 24,946 13 6990 8 17,956 18 2275 14 500 7 1775 20
Use alcohol Normal 62,639 34 26,645 32 35,994 35 5848 37 2478 36 3370 38
Overweight or obese 81,646 44 45,713 54 35,933 35 6248 40 3505 51 2743 31



Alcohol Physical inactivity
No use of alcohol Any leisure time exercise 26,531 14 8295 10 18,236 18 2021 13 593 9 1428 16
No leisure time exercise 15,864 8 3866 5 11,998 12 1655 11 287 4 1368 15
Use alcohol Any leisure time exercise 110,994 59 55,185 65 55,809 54 9087 58 4363 64 4724 53
No leisure time exercise 35,398 19 18,142 21 17,256 17 2966 19 1583 23 1383 16



Body mass index Physical inactivity
Normal Any leisure time exercise 61,772 33 24,312 29 37,460 37 5440 34 2103 31 3337 37
No leisure time exercise 18,139 10 7474 9 10,665 10 1868 12 765 11 1103 12
Overweight or obese Any leisure time exercise 74,473 40 38,401 46 36,072 35 5726 36 2865 42 2861 32
No leisure time exercise 32,204 17 14,115 17 18,089 18 2757 17 1098 16 1659 19

3.1 Single effects of lifestyle factors

Former or current smokers had the highest HR for any solid cancer (HR 1.20, 95 % CI 1.13–1.26 for men and 1.15, 1.09–1.21 for women, Table 3), when compared to never-smokers. Both high alcohol consumption and overweight/obesity were associated with an increased risk in men (HR 1.13, 1.05–1.21 and 1.12, 1.07–1.18, respectively). For women, after adjusting for other lifestyle factors, alcohol consumption and overweight/obesity resulted in a small increased risk of any solid cancer (HR 1.06, 1.00–1.12 and 1.06, 1.01–1.11, respectively). Lack of physical activity increased the risk of any solid cancer by 4 % among men and women, with a borderline statistical significance (HR 1.04, 0.99–1.10 in both groups).

Table 3.

Adjusted hazard ratios (HR) and 95% confidence intervals (CI) of any solid malignant tumors (excluding and including lung cancers) for lifestyle risk factors. METCA consortium, adult cohort, 1972–2015, Finland.


Men
(lung cancer excl.)
Men
(lung cancer incl.)
Women
(lung cancer excl.)
Women
(lung cancer incl.)
HR
95 % CI
HR
95 % CI
HR
95 % CI
HR
95 % CI
Ex- or current smoker vs never smoker 1.20 (1.13–1.26) 1.48 (1.40–1.56) 1.15 (1.09–1.21) 1.27 (1.21–1.34)
Use alcohol vs. no use of alcohol 1.13 (1.05–1.21) 1.14 (1.07–1.21) 1.06 (1.00–1.12) 1.05 (0.99–1.11)
Overweight or obese vs normal weight 1.12 (1.07–1.18) 0.99 (0.95–1.04) 1.06 (1.01–1.11) 1.04 (0.99–1.09)
No leisure time exercise vs any leisure time exercise 1.04 (0.99–1.10) 1.08 (1.03–1.13) 1.04 (0.99–1.10) 1.06 (1.00–1.11)

# adjusted for study, age, calendar time, and other lifestyle risk factors.

In men and women, single factor HRs for current or former smoking were significantly higher when lung cancer was included in the analyses. For men, smoking increased the risk of any solid cancer by 48 % (95 % CI 1.40–1.56), when lung cancer was included in the analyses, in contrast to the observed 20 % increase when lung cancer was excluded. Including lung cancers resulted in lower cancer risk for overweight/obesity in men, as compared to analyses without lung cancers (HR 0.99, 0.95–1.04 vs. HR 1.12, 1.07–1.18, respectively). Regarding alcohol consumption and physical inactivity, including lung cancer in the analyses resulted in minor changes only. For women, the differences in the HRs were small between the two analyses. The biggest difference was for smoking, with HR 1.15, 1.09–1.21 when lung cancers were excluded and HR 1.27, 1.21–1.34 when lung cancers were included.

3.2 The pairwise effects of lifestyle factors

The number of solid cancers (excluding and including lung cancer), person-years, incidence rates and adjusted HRs for all lifestyle factor pairs are shown in Table 4. The ordered age-standardized incidence rates for all lifestyle factor pairs are plotted in Fig. 1 by sex. Men who were former or current smokers and had overweight/obesity had the highest age standardized rate of cancer (460 per 100 000, 95 % CI 443/105-479/105, Table 4). For women, the highest age standardized cancer rates were in physically inactive former or current smokers (469/105, 434/105-507/105). High cancer rates were observed also when smoking was combined with alcohol consumption, for both men (445/105, 431/105-459/105) and women (463/105, 442/105-485/105).

Table 4.

Number of solid malignant tumors (Cancers) and person-years (kPY: person-years in thousands), age standardized incidence rate (Rate) and adjusted hazard ratios (HR) of solid malignant tumors for lifestyle risk factor pairs in men (excluding and including lung cancer). METCA consortium, adult cohort, 1972–2015, Finland.


Excluding lung cancer
Including lung cancer
Risk factor pair Cancers/kPY Rate HR (95 % CI) Cancers/kPY Rate HR (95 % CI)
Smoking Alcohol
Never smoker No use of alcohol 501/75 314 (284, 351) 1.00 510/75 321 (291, 359) 1.00
Use alcohol 1300/224 385 (363, 408) 1.13 (1.02, 1.26) 1330/224 395 (373, 419) 1.18 (1.07, 1.31)
Ex- or current smoker No use of alcohol 556/67 366 (328, 416) 1.20 (1.07, 1.35) 751/66 507 (464, 563) 1.55 (1.39, 1.73)
Use alcohol 4481/666 445 (431, 459) 1.35 (1.23, 1.48) 5687/663 566 (550, 582) 1.72 (1.57, 1.89)
Interaction 0.99 (0.87, 1.13) 0.94 (0.83, 1.06)
p-interaction1 0.915 0.449



Smoking Body mass index
Never smoker Normal 641/134 331 (305, 359) 1.00 656/134 339 (313, 368) 1.00
Overweight or obese 1145/160 388 (364, 417) 1.15 (1.05, 1.27) 1169/160 397 (372, 426) 1.12 (1.03, 1.23)
Ex- or current smoker Normal 1758/306 404 (385, 424) 1.22 (1.12, 1.34) 2458/305 567 (544, 591) 1.63 (1.50, 1.77)
Overweight or obese 3220/413 460 (443, 479) 1.36 (1.25, 1.48) 3894/411 557 (538, 577) 1.56 (1.44, 1.69)
Interaction 0.96 (0.86, 1.07) 0.85 (0.77, 0.95)
p-interaction1 0.735 0.029



Smoking Physical inactivity
Never smoker Any exercise 1395/233 371 (350, 393) 1.00 1429/233 381 (361, 404) 1.00
No exercise 392/66 351 (315, 394) 0.97 (0.87, 1.09) 398/66 357 (321, 401) 0.97 (0.87, 1.08)
Ex- or current smoker Any exercise 3625/530 431 (416, 447) 1.17 (1.10, 1.25) 4559/528 545 (528, 562) 1.43 (1.35, 1.52)
No exercise 1384/199 454 (429, 481) 1.25 (1.16, 1.35) 1831/198 599 (571, 630) 1.58 (1.48, 1.70)
Interaction 1.10 (0.97, 1.24) 1.14 (1.01, 1.29)
p-interaction1 0.534 0.084



Alcohol Body mass index
No use of alcohol Normal 401/68 300 (267, 340) 1.00 513/67 387 (350, 431) 1.00
Overweight or obese 647/73 364 (332, 412) 1.18 (1.05, 1.33) 736/73 428 (393, 478) 1.04 (0.93, 1.16)
Use alcohol Normal 1995/373 400 (382, 419) 1.17 (1.06, 1.30) 2599/372 523 (502, 544) 1.17 (1.07, 1.29)
Overweight or obese 3706/499 450 (434, 467) 1.30 (1.17, 1.44) 4316/498 524 (507, 542) 1.15 (1.05, 1.26)
Interaction 0.94 (0.82, 1.07) 0.95 (0.84, 1.06)
p-interaction1 0.647 0.468



Alcohol Physical inactivity
No use of alcohol Any exercise 705/100 325 (298, 357) 1.00 839/100 396 (367, 432) 1.00
No exercise 333/41 366 (319, 431) 1.03 (0.91, 1.17) 400/41 444 (393, 513) 1.04 (0.92, 1.16)
Use alcohol Any exercise 4307/663 426 (413, 440) 1.12 (1.04, 1.22) 5141/662 510 (496, 526) 1.12 (1.04, 1.21)
No exercise 1436/223 444 (420, 469) 1.18 (1.07, 1.29) 1823/222 563 (536, 591) 1.22 (1.12, 1.32)
Interaction 1.01 (0.88, 1.16) 1.05 (0.92, 1.19)
p-interaction1 0.915 0.497



Body mass index Physical inactivity
Normal Any exercise 1794/333 379 (361, 398) 1.00 2254/331 478 (458, 499) 1.00
No exercise 598/107 391 (359, 426) 1.06 (0.97, 1.16) 849/107 560 (522, 601) 1.16 (1.07, 1.25)
Overweight or obese Any exercise 3185/419 434 (418, 452) 1.13 (1.06, 1.19) 3680/418 505 (487, 524) 1.02 (0.97, 1.08)
No exercise 1143/151 452 (424, 485) 1.17 (1.08, 1.26) 1338/150 527 (497, 561) 1.06 (0.99, 1.13)
Interaction 0.97 (0.87, 1.09) 0.89 (0.81, 0.98)
p-interaction1 0.869 0.070
1P-interaction: p-value for H0: HR (interaction) = 1.00, corrected for multiple comparisons (Benjamini-Hochberg)

Fig. 1.

Fig. 1

Age-standardized incidence rate (per 100,000 person years) of solid malignant tumors (excluding lung cancer) with 95% confidence intervals for lifestyle risk factor pairs by sex. METCA consortium, adult cohort, 1972–2015, Finland.

Both men and women exposed to any two of the four studied lifestyle factors had significantly elevated HRs compared to those not exposed to either of the factors in the studied pair (Table 4, Table 5 and Supplementary Fig. 1). Former or current smokers with a BMI of ≥ 25 kg/m2 had the highest risk of any cancer (HR 1.36, 1.25–1.48), compared to never-smoker men with BMI < 25 kg/m2. Men who smoked and consumed alcohol had an almost similar increase in cancer risk as smoking men with overweight/obesity (HR 1.35, 1.23–1.48). For women, the highest HRs were observed for former or current smokers who also consumed alcohol (HR 1.22, 1.14–1.30) or were physically inactive (HR 1.22, 1.12–1.33). In general, when including lung cancer in the pairwise inspection, the effect of smoking was larger and the effect of overweight/obesity smaller (Table 5). For men, the highest HR was observed for smokers who also consumed alcohol (HR 1.72, 1.57–1.89). For women, smoking combined with alcohol consumption resulted in HR 1.33 (95 % CI 1.24–1.42). The highest HR, however, was seen for physically inactive smoking women (1.38, 1.27–1.49). Results of the sensitivity analyses excluding the first two years of follow-up are shown in Supplementary Tables 1-3.

Table 5.

Number of solid malignant tumors (Cancers) and person-years (kPY: person-years in thousands), age standardized incidence rate (Rate) and adjusted hazard ratios (HR) of solid malignant tumors for lifestyle risk factor pairs in women (excluding and including lung cancer). METCA consortium, adult cohort, 1972–2015, Finland.


Excluding lung cancer
Including lung cancer
Risk factor pair Cancers/kPY Rate HR (95 % CI) Cancers/kPY Rate HR (95 % CI)
Smoking Alcohol
Never smoker No use of alcohol 2518/383 334 (315, 356) 1.00 2596/382 342 (323, 364) 1.00
Use alcohol 2454/432 396 (379, 414) 1.06 (1.00, 1.13) 2499/432 403 (386, 422) 1.06 (1.00, 1.12)
Ex- or current smoker No use of alcohol 362/55 414 (365, 473) 1.17 (1.05, 1.30) 415/55 462 (411, 524) 1.32 (1.19, 1.46)
Use alcohol 1972/365 463 (442, 485) 1.22 (1.14, 1.30) 2171/364 510 (488, 533) 1.33 (1.24, 1.42)
Interaction 0.98 (0.87, 1.11) 0.95 (0.85, 1.07)
p-interaction1 0.881 0.468



Smoking Body mass index
Never smoker Normal 1965/383 367 (349, 385) 1.00 2008/382 374 (356, 393) 1.00
Overweight or obese 2945/422 363 (343, 387) 1.09 (1.03, 1.15) 3023/422 372 (352, 395) 1.08 (1.02, 1.15)
Ex- or current smoker Normal 1179/233 457 (430, 484) 1.21 (1.12, 1.30) 1326/233 516 (488, 546) 1.35 (1.26, 1.45)
Overweight or obese 1114/178 452 (423, 484) 1.20 (1.11, 1.29) 1217/177 490 (460, 522) 1.29 (1.20, 1.39)
Interaction 0.91 (0.82, 1.00) 0.88 (0.80, 0.97)
p-interaction1 0.353 0.043



Smoking Physical inactivity
Never smoker Any exercise 3300/554 373 (358, 389) 1.00 3374/554 381 (365, 397) 1.00
No exercise 1656/258 362 (338, 388) 1.03 (0.97, 1.09) 1701/257 369 (345, 396) 1.03 (0.97, 1.09)
Ex- or current smoker Any exercise 1617/296 452 (430, 476) 1.14 (1.07, 1.21) 1774/295 495 (471, 520) 1.24 (1.17, 1.32)
No exercise 715/123 469 (434, 507) 1.22 (1.12, 1.33) 811/123 528 (491, 568) 1.38 (1.27, 1.49)
Interaction 1.05 (0.94, 1.16) 1.08 (0.98, 1.19)
p-interaction1 0.674 0.240



Alcohol Body mass index
No use of alcohol Normal 1007/180 346 (320, 375) 1.00 1055/180 359 (333, 388) 1.00
Overweight or obese 1815/250 334 (308, 369) 1.10 (1.02, 1.19) 1900/250 347 (320, 382) 1.09 (1.02, 1.18)
Use alcohol Normal 2140/436 419 (401, 438) 1.10 (1.02, 1.19) 2282/435 446 (428, 465) 1.10 (1.02, 1.19)
Overweight or obese 2238/348 424 (403, 446) 1.13 (1.05, 1.22) 2336/347 441 (420, 464) 1.10 (1.02, 1.19)
Interaction 0.94 (0.85, 1.03) 0.92 (0.84, 1.01)
p-interaction1 0.534 0.128



Alcohol Physical inactivity
No use of alcohol Any exercise 1644/263 337 (315, 362) 1.00 1723/263 350 (328, 375) 1.00
No exercise 1205/170 357 (324, 396) 1.07 (1.00, 1.16) 1258/170 368 (336, 408) 1.07 (1.00, 1.15)
Use alcohol Any exercise 3269/587 426 (410, 442) 1.08 (1.01, 1.15) 3423/586 444 (429, 461) 1.06 (0.99, 1.13)
No exercise 1156/209 421 (396, 448) 1.09 (1.01, 1.19) 1243/209 451 (425, 479) 1.10 (1.02, 1.19)
Interaction 0.95 (0.86, 1.04) 0.97 (0.88, 1.07)
p-interaction1 0.644 0.572



Body mass index Physical inactivity
Normal Any exercise 2353/455 405 (388, 423) 1.00 2483/455 426 (409, 444) 1.00
No exercise 789/161 372 (344, 402) 0.97 (0.90, 1.05) 849/161 398 (369, 429) 0.98 (0.91, 1.06)
Overweight or obese Any exercise 2528/384 389 (369, 411) 1.02 (0.96, 1.08) 2631/384 403 (383, 426) 1.00 (0.95, 1.06)
No exercise 1516/212 396 (369, 428) 1.11 (1.04, 1.19) 1594/212 415 (387, 448) 1.11 (1.04, 1.19)
Interaction 1.13 (1.02, 1.25) 1.13 (1.02, 1.24)
p-interaction1 0.185 0.058
1P-interaction: p-value for H0: HR (interaction) = 1.00, corrected for multiple comparisons (Benjamini-Hochberg)

3.3 Interactions of effects

Measures of interactions on a multiplicative scale between pairwise lifestyle factors are shown in Table 4. No statistically significant interactions were detected, when adjusting for multiple comparison. When lung cancer was included in the analyses, significant negative interactions between smoking and BMI were found: the joint effect of smoking and BMI together was smaller (15 % in men and 12 % in women) than the product of the estimated effects of smoking and BMI alone (Table 5).

4. Discussion

Both men and women exposed to any two of the four studied lifestyle factors had a significantly elevated risk of solid malignant tumors when lung cancer was excluded from the analysis. For men, the highest risk was observed for smokers with a BMI of ≥25 kg/m2 (HR 1.36, 95 % CI 1.25–1.48), followed by smokers consuming alcohol (HR 1.35, 1.23–1.48). For women, the highest risk was observed for smokers consuming alcohol (HR 1.22, 1.14–1.30) or being physically inactive (HR 1.22, 1.12–1.33). When including lung cancer, the highest HRs among men were observed for smokers who also consumed alcohol (HR 1.72, 1.57–1.89) and among women for smokers who were physically inactive (HR 1.38, 1.27–1.49). No statistically significant interactions were observed between any studied lifestyle pairs, except for smoking and BMI in the analyses including lung cancer.

We examined the risk of any solid cancer both with and without lung cancer cases. This was done because smoking is so strongly associated with lung cancer that it could dominate the results and obscure other significant associations. When lung cancer cases were excluded from the analysis, the cancer risk among those who smoked or consumed alcohol appeared somewhat smaller than when lung cancer cases were included. Overweight/obesity increased the cancer risk among men who were ex- or current smokers or who consumed alcohol. When lung cancer cases were included, we found an interaction between smoking and overweight/obesity: ex- or current smokers with overweight/obesity had lower risk of any cancer compared to smokers with normal weight, implying that overweight/obesity may be protective against cancer among smokers. Similarly, the risk of cancer among men who consumed alcohol and were overweight/obese appeared lower compared to those with normal weight, although no statistically significant interaction was found. However, the confidence intervals of these HRs were clearly overlapping and the confidence intervals for interaction term were close to 1.00, so no strong conclusions can be made. It is probable that the difference is affected by heavy smokers typically having lower body weight, especially if already with an undiagnosed lung cancer. This would result in a misleading pairwise hazard ratio when examining body weight and smoking together.

Although physical inactivity is associated with an increased cancer risk (Wild et al., 2020), in our study physical inactivity appeared to have only a minor effect on the pairwise associations. This may be since the METCA cohort studies surveyed only leisure time physical activity and did not include physical activity during the working day. Especially during earlier METCA substudies in the 1970 s working days were more physically strenuous and leisure time physical activity was not common. Hence physical inactivity variable in our study might not describe the 24-hour physical activity correctly.

Our results are in accordance with previous studies. It has been shown that smoking combined with high alcohol use is associated with especially high risk of laryngeal and gi-tract cancers (Steevens et al., 2010, Maasland et al., 2014, Ramroth et al., 2004) and colon and prostate cancers (Viner et al., 2019). These studies found a significant interaction between current smoking and high alcohol use. However, we did not find any interaction between smoking and alcohol use when all solid cancers (excl non-melanoma skin) were analysed together, but our previous study (Roos et al., 2022) has found a positive interaction between smoking and alcohol use when only colon cancer risk was analyzed.

The strengths of the study include large sample size as the data include seven different national cohort studies. This improves statistical power to detect possible interactive effect. The follow-up period is long and enables reliable evaluation of exposure effects with long latency. Cancer diagnoses are based on reliable and conclusive register data on practically all diagnosed cancers in Finland (Leinonen et al., 2017). We adjusted for study cohort effect in the baseline hazard. According to the earlier study with the same dataset no significant heterogeneity was observed between the cohort-specific risk factor effects (Pitkäniemi et al., 2020).

We chose to examine any solid cancer (excluding non-melanoma skin cancer) as the primary outcome, although risk factors and their pairwise effects are likely to vary between cancers. This may attenuate reported associations somewhat. Among the weaknesses of our study was that exposure information was available only from the baseline. Exposure status may have changed during the follow-up and for example yet undiagnosed cancer may cause substantial changes in behavior. Results of the sensitivity analyses suggested that reverse causation does not play a major role in these associations, since the exclusion of the first two years of follow up did not much affect the estimates. As another limitation, some of the gathered health survey data is based on face-to-face health examination which might cause participation bias. It is known that for example feeling sick prohibits participation in face-to-face health examination, especially among older participants (Tolonen et al., 2017) and overall, the participants tend to be healthier than non-participants (Strandhagen et al., 2010). Instead of considering all possible combinations of exposures simultaneously, we analyzed one pair of exposures at a time, including interaction terms of the pair and assuming multiplicative effects for the other risk factors. The binary categorization into exposed and non-exposed does not allow the assessment of the dose–response of the exposure. Our analyses do hence not consider more complex combinatory effects. The number of those simultaneously exposed to several risk factors would become very small even with the large sample size of our current study, leading to very little statistical power to detect any higher order associations.

In previous research cancer risk has been studied using lifestyle indexes, combining different lifestyle factors together (Naudin et al., 2020). In our study the effect of lifestyle factors on overall cancer risk appeared independent and hence combining these factors may be done. However, it should be noted that different lifestyle factors do not have the same value regarding cancer risk. For example, physical inactivity and smoking are not equivalent risk factors. The approach based on lifestyle indexes is quite different than what we have done here and should be considered in a separate study.

Our results suggest that since lifestyle effects appeared largely independent, it is useful to focus preventive strategies on those lifestyle factors that have the largest impact on cancer risk on an individual, but also on community level and on those sub-populations that have multiple risk factors. Not long ago an editorial in JNCI (Samet, 2018) discussed the complicated relationship between smoking, obesity and lung cancer as research has shown that while BMI is inversely associated with lung cancer risk, central obesity appears to increase the risk (GBD 2015 Tobacco Collaborators et al., 2017). The editorial raised the concern that smoking is still highly prevalent, and the obesity epidemic shows no evidence of declining, and both are powerful risk factors for cancer. In our study, current smokers who were also obese had the highest risk of any solid cancer (when excluding lung cancer). A recent Australian study estimated that a notable number of cancers attributable to obesity, smoking and alcohol consumption and their combinations are preventable (Arriaga et al., 2017). For these reasons, the interplay of these risk factors needs to be better understood.

In conclusion, the main finding was that for almost all pairs of lifestyle factors, the relative risk of any cancer increases multiplicatively in relation to the respective relative risks generated by either exposure in the absence of the other. Especially current smoking combined with other lifestyle factors at any exposure level resulted in highest pairwise risks, both in men and women. These results highlight the importance of smoking prevention, but also the importance of preventing obesity and reducing alcohol consumption.

Funding

This work was supported by the Finnish Cancer Foundation.

CRediT authorship contribution statement

Eira Roos: Writing – original draft, Investigation, Conceptualization. Sanna Heikkinen: Writing – original draft, Methodology, Investigation, Formal analysis, Data curation, Conceptualization. Karri Seppä: Writing – original draft, Methodology, Investigation, Formal analysis, Data curation, Conceptualization. Olli Pietiläinen: Investigation, Conceptualization. Heidi Ryynänen: Writing – original draft, Investigation, Formal analysis, Data curation. Maarit Laaksonen: Writing – review & editing. Teemu Roos: Writing – review & editing, Methodology, Investigation. Paul Knekt: Writing – review & editing. Satu Männistö: Writing – review & editing. Tommi Härkänen: Writing – review & editing. Pekka Jousilahti: Writing – review & editing. Seppo Koskinen: Writing – review & editing. Johan G. Eriksson: Writing – review & editing. Nea Malila: Writing – review & editing, Supervision, Resources, Project administration, Methodology, Investigation, Funding acquisition, Conceptualization. Ossi Rahkonen: Writing – review & editing, Supervision, Resources, Methodology, Investigation, Funding acquisition, Conceptualization. Janne Pitkäniemi: Writing – review & editing, Supervision, Resources, Project administration, Methodology, Investigation, Funding acquisition, Conceptualization.

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Footnotes

Appendix A

Supplementary data to this article can be found online at https://doi.org/10.1016/j.pmedr.2024.102607.

Appendix A. Supplementary data

The following are the Supplementary data to this article:

Supplementary data 1
mmc1.docx (294.4KB, docx)

Data availability

The authors do not have permission to share data.

References

  1. Arriaga M.E., Vajdic C.M., Canfell K., MacInnis R., Hull P., Magliano D.J., et al. The burden of cancer attributable to modifiable risk factors: the Australian cancer-PAF cohort consortium. BMJ Open. 2017;7(6):e016178. doi: 10.1136/bmjopen-2017-016178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Benjamini Y., Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B. 1995;57(1):289–300. [Google Scholar]
  3. Borodulin, K., Tolonen, H., Jousilahti, P., Jula, A., Juolevi, A., Koskinen, S., et al. Cohort profile: The national FINRISK study. Int. J. Epidemiol. 2018;47(3):696-696i. [DOI] [PubMed]
  4. Chiolero A., Faeh D., Paccaud F., Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am. J. Clin. Nutr. 2008;87(4):801–809. doi: 10.1093/ajcn/87.4.801. [DOI] [PubMed] [Google Scholar]
  5. Dartois L., Fagherazzi G., Boutron-Ruault M.-C., Mesrine S., Clavel-Chapelon F. Association between five lifestyle habits and cancer risk: Results from the E3N cohort. Cancer Prev Res. 2014;7(5):516–525. doi: 10.1158/1940-6207.CAPR-13-0325. [DOI] [PubMed] [Google Scholar]
  6. Eriksson J.G. Early growth, and coronary heart disease and type 2 diabetes: Experiences from the Helsinki Birth Cohort Studies. Int. J. Obesity. 2006;30(4):S18–S22. doi: 10.1038/sj.ijo.0803515. [DOI] [PubMed] [Google Scholar]
  7. GBD 2015 Tobacco Collaborators, M.B., Fullman, N., Ng, M., Salama, J.S., Abajobir, A., Abate, K.H., et al. 2017. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet (London, England). 2017 May 13;389(10082):1885–906. [DOI] [PMC free article] [PubMed]
  8. Hadrien C., Shizuka S., Manami I., Motoki I., Norie S., Taichi S., et al. Impact of five modifiable lifestyle habits on the probability of cancer occurrence in a Japanese population-based cohort: Results from the JPHC study. Prevent. Med. 2013;57(5):685–689. doi: 10.1016/j.ypmed.2013.08.030. [DOI] [PubMed] [Google Scholar]
  9. Härkänen T., Kaikkonen R., Virtala E., Koskinen S. Inverse probability weighting and doubly robust methods in correcting the effects of non-response in the reimbursed medication and self-reported turnout estimates in the ATH survey. BMC Public Health. 2014;14(1):1150. doi: 10.1186/1471-2458-14-1150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Heistaro S. Methodology report: Health 2000 survey. 2008.
  11. Howard D.H., Bach P.B., Berndt E.R., Conti R.M. Pricing in the market for anticancer drugs. J. Econ. Perspect. 2015;29(1):139–162. doi: 10.1257/jep.29.1.139. PMID: 28441702. [DOI] [PubMed] [Google Scholar]
  12. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Personal habits and indoor combustions. Volume 100 E. A review of human carcinogens. IARC Monogr Eval Carcinog risks to humans. 2012;100:1–538. [PMC free article] [PubMed]
  13. Katzke, V.A., Kaaks, R., Kühn, T. Lifestyle and Cancer Risk. Cancer J. [Internet]. 2015 [cited 2018 Feb 3];21(2):104–10. [DOI] [PubMed]
  14. Knekt P., Rissanen H., Järvinen R., Heliövaara M. Cohort profile: The Finnish mobile clinic health surveys FMC, FMCF and MFS. Int. J. Epidemiol. 2017;46(6):1760–1761i. doi: 10.1093/ije/dyx092. [DOI] [PubMed] [Google Scholar]
  15. Lahelma E., Aittomäki A., Laaksonen M., Lallukka T., Martikainen P., Piha K., Rahkonen O., Saastamoinen P. Cohort profile: the Helsinki Health Study. Int. J. Epidemiol. 2013;42(3):722–730. doi: 10.1093/ije/dys039. Epub 2012 Mar 31 PMID: 22467288. [DOI] [PubMed] [Google Scholar]
  16. Leinonen M.K., Miettinen J., Heikkinen S., Pitkäniemi J., Malila N. Quality measures of the population-based Finnish Cancer Registry indicate sound data quality for solid malignant tumours. Eur. J. Cancer. 2017 doi: 10.1016/j.ejca.2017.02.017. [DOI] [PubMed] [Google Scholar]
  17. Levi F. Cancer prevention: epidemiology and perspectives. Eur. J. Cancer. 1999.Dec;35(14):1912-24. Review. PubMed PMID: 10711234. [DOI] [PubMed]
  18. Maasland D.H., van den Brandt P.A., Kremer B., Goldbohm R.A., Schouten L.J. Alcohol consumption, cigarette smoking and the risk of subtypes of head-neck cancer: results from the Netherlands Cohort Study. BMC Cancer. 2014;14(1):187. doi: 10.1186/1471-2407-14-187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Meropol N.J., Schrag D., Smith T.J., Mulvey T.M., Langdon R.M., Jr, Blum D., et al. American Society of Clinical Oncology. American Society of Clinical Oncology guidance statement: the cost of cancer care. J. Clin. Oncol. 2009;27(23):3868–3874. doi: 10.1200/JCO.2009.23.1183. [DOI] [PubMed] [Google Scholar]
  20. Michaud D.S., Giovannucci E., Willett W.C., Colditz G.A., Stampfer M.J., Fuchs C.S. Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA. 2001;286(8):921. doi: 10.1001/jama.286.8.921. [DOI] [PubMed] [Google Scholar]
  21. Naudin, S., Viallon, V., Hashim, D., Freisling, H., Jenab, M., Weiderpass, E., et al. Healthy lifestyle and the risk of pancreatic cancer in the EPIC study. Eur. J. Epidemiol. 2020 Oct;35(10):975-986. doi: 10.1007/s10654-019-00559-6. Epub 2019 Sep 28. PMID: 31564045; PMCID: PMC7116136. [DOI] [PMC free article] [PubMed]
  22. Olsen J.H., Andersen A., Dreyer L., Pukkala E., Tryggvadottir L., Gerhardsson de Verdier M., Winther J.F. Summary of avoidable cancers in the Nordic countries. APMIS Suppl. 1997;76:141–146. doi: 10.1111/j.1600-0463.1997.tb05617.x. PubMed PMID: 9462826. [DOI] [PubMed] [Google Scholar]
  23. Parkin D.M., Boyd L., Walker L.C. 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer. 2011;105 Suppl 2(S2):S77–S81. doi: 10.1038/bjc.2011.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pitkäniemi J., Heikkinen S., Seppä K., Ryynänen H., Hakanen T., Eriksson J.G., et al. Pooling of Finnish population-based health studies: Lifestyle risk factors of colorectal and lung cancer. Acta Oncologica. 2020;59(11):1338–1342. doi: 10.1080/0284186X.2020.1789214. [DOI] [PubMed] [Google Scholar]
  25. Poirier A.E., Ruan Y., Volesky K.D., King W.D., O'Sullivan D.E., Gogna P., Walter S.D., et al. The current and future burden of cancer attributable to modifiable risk factors in Canada: Summary of results. Prev Med. 2019;122:140–147. doi: 10.1016/j.ypmed.2019.04.007. [DOI] [PubMed] [Google Scholar]
  26. Ramroth H., Dietz A., Becher H. Interaction effects and population-attributable risks for smoking and alcohol on laryngeal cancer and its subsites. Methods Inf Med. 2004;43(5):499–504. [PubMed] [Google Scholar]
  27. Roos, E., Seppä, K., Pietiläinen, O., Ryynänen, H., Heikkinen, S., Eriksson, J.G., Härkän et al. METCA Study Group. Pairwise association of key lifestyle factors and risk of colorectal cancer: a prospective pooled multicohort study. Cancer Rep. (Hoboken). 2022 Nov;5(11):e1612. [DOI] [PMC free article] [PubMed]
  28. Samet, J.M. Lung Cancer, Smoking, and Obesity: It’s Complicated. Vol. 110, Journal of the National Cancer Institute. NLM (Medline); 2018. p. 795–6. [DOI] [PubMed]
  29. Steevens J., Schouten L.J., Goldbohm R.A., van den Brandt P.A. Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: A prospective cohort study. Gut. 2010;59(1):39–48. doi: 10.1136/gut.2009.191080. [DOI] [PubMed] [Google Scholar]
  30. Strandhagen E., Berg C., Lissner L., Nunez L., Rosengren A., Torén K., et al. Selection bias in a population survey with registry linkage: Potential effect on socioeconomic gradient in cardiovascular risk. Eur. J. Epidemiol. 2010;25:163–172. doi: 10.1007/s10654-010-9427-7. [DOI] [PubMed] [Google Scholar]
  31. Tolonen H., Lundqvist A., Jääskeläinen T., Koskinen S., Koponen P. Reasons for non-participation and ways to enhance participation in health examination surveys-the Health 2011 Survey. Eur. J. Public Health. 2017;27(5):909–911. doi: 10.1093/eurpub/ckx098. PMID: 28957480. [DOI] [PubMed] [Google Scholar]
  32. Torre L.A., Siegel R.L., Ward E.M., Jemal A. Global cancer incidence and mortality rates and trends–An update. Cancer Epidemiol. Biomarkers Prev. 2016;25(1):16–27. doi: 10.1158/1055-9965.EPI-15-0578. [DOI] [PubMed] [Google Scholar]
  33. Viner B., Barberio A.M., Haig T.R., Friedenreich C.M., Brenner D.R. The individual and combined effects of alcohol consumption and cigarette smoking on site-specific cancer risk in a prospective cohort of 26,607 adults: results from Alberta’s Tomorrow Project. Cancer Causes Control. 2019 doi: 10.1007/s10552-019-01226-7. [DOI] [PubMed] [Google Scholar]
  34. Wild, C.P., Weiderpass, E., Stewart, B.W., editors (2020). World Cancer Report: Cancer Research for Cancer Prevention. Lyon, France: International Agency for Research on Cancer. Available from: http://publications.iarc.fr/586. [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary data 1
mmc1.docx (294.4KB, docx)

Data Availability Statement

The authors do not have permission to share data.


Articles from Preventive Medicine Reports are provided here courtesy of Elsevier

RESOURCES